Sangamo BioSciences Announces Presentation of ZFP Therapeutic Data,From Nerve Regeneration Program at American Society for Neural,Therapy and Repair Meeting ( to apply its ZFP Technology to enhance...)

HOME >> MEDICINE >> TECHNOLOGY

Sangamo BioSciences Announces Presentation of ZFP Therapeutic Data,From Nerve Regeneration Program at American Society for Neural,Therapy and Repair Meeting

to apply its ZFP Technology to enhance the production of protein pharmaceuticals. For more information about Sangamo, visit the company's web site at http://www.sangamo.com.

This press release may contain forward-looking statements based on Sangamo's current expectations. These forward-looking statements include, without limitation, references to the research and development of novel ZFP TFs and ZFNs as ZFP Therapeutics, applications of Sangamo's ZFP TF technology platform and clinical trials of ZFP Therapeutics. Actual results may differ materially from these forward-looking statements due to a number of factors, including technological challenges, uncertainties relating to the initiation and completion of stages of ZFP Therapeutic clinical trials, Sangamo's ability to develop commercially viable products and technological developments by our competitors. See the company's SEC filings, and in particular, the risk factors described in the company's Annual Report on Form 10-K and its most recent 10-Q. Sangamo BioSciences, Inc. assumes no obligation to update the forward-looking information contained in this press release.

CONTACT: Elizabeth Wolffe, Ph.D., Sangamo BioSciences, Inc.,+1-510-970-6000, ext. 271, or ; or Justin Jackson(media), Burns McClellan, Inc., +1-212-213-0006, or ewolffe@sangamo.com jjackson@burnsmc.com

Web site: http://www.sangamo.com//

Ticker Symbol: (NASDAQ-NMS:SGMO)

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company

Page: 1 2 3 4
Related medicine technology :

1. Sangamo BioSciences Announces Presentation of Phase 1 ZFP Therapeutic Data at American Diabetes Association Meeting
2. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
3. YM BioSciences Announces Preclinical Data Confirming Nimotuzumab Binds to the EGF Receptor and Potentiates Radiotherapy
4. IR BioSciences Announces Promising Data from Study of Its Compound Homspera
5. YM BioSciences Reports AeroLEF Randomized Phase IIb Trial Meets Primary Endpoint in Patients with Post-Surgical Pain
6. ImmuneRegen BioSciences Announces Promising Data on Homspera Suggesting Potential as a Co-Therapeutic Agent
7. Study in Cell by Magen BioSciences Co-Founder David E. Fisher Identifies New Roles in Skin Cancer Prevention for Key Tumor Suppressor Protein
8. IR BioSciences Announces Data Demonstrating Radilex Stimulation of Stem Cells Results in Hematopoietic Recovery Following Lethal Irradiation
9. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
10. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
11. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis

Post Your Comments:

(Date:11/20/2009)...., Nov. 20 /PRNewswire-FirstCall/ -- Landauer, ... the fiscal fourth quarter and full year of 2009 p...company will host a conference call for investors ... Time. Investors may access the live call by diali...da), or 480-629-9835 (international callers), or b...

(Date:11/20/2009)..., Nov. 20 Reportlinker.com announc...in its catalogue. ,, Blood Pressure Monitoring...alysis ,, http://www.reportlinker.com/p01643...nts---A-World-Market-Analysis.html#utm_source=prne...re ,, Measurement of blood pressure is not on...

(Date:11/20/2009)..., Nov. 20 ,, Reportlinker.com ...ilable in its catalogue. ,, India Medical Equi... http://www.reportlinker.com/p0164658/India-Medi...5.html#utm_source=prnewswire&utm_medium=pr&..., India Medical Equipment Market Analysis and For...

[0] Landauer, Inc. Sets Date and Time for Announcement of Fiscal Fourth Quarter and Full Year 2009 Results [0] Reportlinker Adds Blood Pressure Monitoring & Measurement Instruments - A World Market Analysis [0] Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015

...irst Approved Systemic Therapy to Treat the Diseas...,Bayer HealthCare Pharmaceuticals and Onyx Pharmac... The New England Journal of Medicine published,res...(R) (sorafenib),tablets decreased the absolute ris...able hepatocellular carcinoma (HCC), or liver canc...

...23 Sound Pharmaceuticals (SPI) has filed,an Inves...he clinical,testing of a proprietary formulation o...ed hearing loss or ototoxicity. The oral capsule,c...anced stage lung cancer,and head and neck cancer p...s marks the second development program for SPI to ...

Other Medicine Technology:The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 2 The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 3 The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 4 The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 5 The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 6 Sound Pharmaceuticals Files Second IND with the FDA for the Prevention of Chemotherapy Induced Hearing Loss in Advanced Stage Cancer 2

The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer Sound Pharmaceuticals Files Second IND with the FDA for the Prevention of Chemotherapy Induced Hearing Loss in Advanced Stage Cancer

(Date:11/21/2009)... HAPPYneuron,s most popular and addi...hone and iPod Touch. , Mo...neuron,s most popular and addictive game, SplitWor... Split Words is designed to help banish that ,tip ...ds iPhone brain game challenges the brain by enc...

(Date:11/21/2009)... New Haven Dental Group merges their... Branford, CT. , (PRWEB) ...omprised of partners Dr. David Gibson, Dr. Dean Cl...r has just merged their growing practice with that...When Dr. Pickman decided he wanted to retire from ...

(Date:11/20/2009)...Pioneering Neurologist Closer to Understanding Bra...PRNewswire-USNewswire/ -- Dr. Jeremy Schmahmann, P...d neurologist at the Massachusetts General Hospita...is laboratory,s research on the new field of study...nk Foundation. ,, Dr. Schmahmann is an award-wi...

(Date:11/20/2009)..., WASHINGTON, Nov. 20 T...ators to modify health care reform legislation rel...ding a health insurance individual coverage mandat...eable mandate will minimize adverse selection stem...prescribed by the bill. ,, "The individual mand...

(Date:11/20/2009)...QUINCY, Mass., Nov. 20 Following a...t Company removed from sale Shedd,s Country Crock ...d Shedd,s Country Crock ® Side Dishes DELUXE ...ergen. ,, The following code dates and UPCs ar...de Dishes DELUXE Cheddar Broccoli Rice 21 oz, UPC ...

Breaking Medicine News(10 mins):Health News:HAPPYneuron releases iPhone Brain Game 2 Health News:HAPPYneuron releases iPhone Brain Game 3 Health News:New Haven Dental Group Expands Their Vision 2 Health News:MINDlink Foundation Launches to Connect the Cerebellum to Cures 2 Health News:Actuaries to Senate: Strengthen Individual Mandate 2 Health News:Stop & Shop Alerts Customers to Voluntary Recall by Unilever 2

[0] HAPPYneuron releases iPhone Brain Game [0] New Haven Dental Group Expands Their Vision [0] MINDlink Foundation Launches to Connect the Cerebellum to Cures [0] Actuaries to Senate: Strengthen Individual Mandate [0] Stop & Shop Alerts Customers to Voluntary Recall by Unilever

... Winegrowers are affected by the type 3 virus whic...y of grapevines//. But most of the winegrowers...are tested vines and are free from the virus. New ...management and detection. Mr Manson said that the ...

...arenicline or Chantix promises to be more effectiv...the habit In addition it has also shown to promote...lts of three studies published in the Journal of t...t dopamine release to curb cravings and at the sam...

...ue to the several previous studies, Geoffrey R. Ho... his colleagues have revealed that exposure// to r...ens and kids. After the chornobyl radiation-ac...adioactive iodine. In 1986, an accident at the...

... unions have accused the Government; of trying to ...uraged and called on large private// sector compan...services. Explaining that the notice on the ...ice-provider to a commissioning-led organisation.'...

...ficials have reported that inhabitants of Phet whe...ered about bird flu// since they had a feast on th...wer northern province of Phichit are trying to cre...it to the area that people were disregarding the t...

...ajor Wyeth Tuesday launched its blockbuster vaccin...ococcal disease among infants and toddlers//. ...ed by streptococcus pneumoniae, also known as the ...l pneumonia, septicaemia and bacteraemia (bacteria...

Other Medicine News:Health News:New Drug to Help Smokers Kick the Habit 2 Health News:Chornobyl Incident Proved Increased Risk of Thyroid Cancer from Radioactive Iodine 2 Health News:Government Accused Of Yielding NHS To Outside Interests 2

Leaf Roll Disease a Cause of Concern to Wine Growers New Drug to Help Smokers Kick the Habit Chornobyl Incident Proved Increased Risk of Thyroid Cancer from Radioactive Iodine Government Accused Of Yielding NHS To Outside Interests People In Thailand Not Bothered About Bird Flu Wyeth Launches Vaccine for Pneumococcal Disease in India

Steinman Pins, Threaded

Skeletal Traction Pins, Half Pin with Cove Point

Skeletal Traction Pins, Full Pin with Cove Point

Instera Pins

Medicine Products:

Steinman Pins, Threaded Skeletal Traction Pins, Half Pin with Cove Point Skeletal Traction Pins, Full Pin with Cove Point Instera Pins

( to apply its ZFP Technology to enhance...)Sangamo BioSciences Announces Presentation of ZFP Therapeutic Data,From Nerve Regeneration Program at American Society for Neural,Therapy and Repair Meeting,Health